Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice

Clinical and Experimental Immunology

Volumn 175, Issue 2, 2014, Pages 192-201

  Wang, J J ^a   Yang, G X ^a   Zhang, W C ^a   Lu, L ^d   Tsuneyama, K ^e   Kronenberg, M ^b   Vela J L ^b   Lopez Hoyos, M ^f   He, X S ^a   Ridgway, W M ^c   Leung, P S C ^a   Gershwin, M E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d NANJING NORMAL UNIVERSITY   (China)

^e UNIVERSITY OF TOYAMA   (Japan)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Anti mitochondrial autoantibodies; Cholangitis; Immune tolerance; Microbial aetiology; Primary biliary cirrhosis

Indexed keywords

ANTIGEN; GLYCOSPHINGOLIPID; MITOCHONDRION ANTIBODY; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY TRACT DISEASE; CHOLANGITIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; IMMUNOPATHOLOGY; MOLECULAR MIMICRY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL;

ANTI-MITOCHONDRIAL AUTOANTIBODIES; CHOLANGITIS; IMMUNE TOLERANCE; MICROBIAL AETIOLOGY; PRIMARY BILIARY CIRRHOSIS;

ANIMALS; ANTIBODIES; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CHOLANGITIS; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GLYCOSPHINGOLIPIDS; LIVER; LIVER ABSCESS; LIVER CIRRHOSIS, BILIARY; MICE; MICE, INBRED NOD; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NATURAL KILLER T-CELLS; SPHINGOMONADACEAE;

EID: 84891601040     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12224     Document Type: Article

References (66)

1. Selmi C, Diana A, Cocchi CA, Zuin M, Gershwin ME. Environmental factors and the induction of autoimmunity in primary biliary cirrhosis. Expert Rev Clin Immunol 2008; 4:239-245.
2. Selmi C, Leung PS, Sherr DH etal. Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. J Autoimmun 2012; 39:272-284.
3. Selmi C, Lu Q, Humble MC. Heritability versus the role of the environment in autoimmunity. J Autoimmun 2012; 39:249-252.
4. Berer K, Krishnamoorthy G. Commensal gut flora and brain autoimmunity: a love or hate affair? Acta Neuropathol (Berl) 2012; 123:639-651.
5. Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 2012; 39:222-228.
6. Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut microbes 2012; 3:4-14.
7. Smyk DS, Bogdanos DP, Kriese S, Billinis C, Burroughs AK, Rigopoulou EI. Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside. Clin Res Hepatol Gastroenterol 2012; 36:110-121.
8. Israeli E, Agmon-Levin N, Blank M, Chapman J, Shoenfeld Y. Guillain-Barre syndrome-a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol 2012; 42:121-130.
9. Duarte-Rey C, Bogdanos D, Yang CY etal. Primary biliary cirrhosis and the nuclear pore complex. Autoimmun Rev 2012; 11:898-902.
10. Nian H, Liang D, Zuo A etal. Characterization of autoreactive and bystander IL-17+ T cells induced in immunized C57BL/6 mice. Invest Ophthalmol Vis Sci 2012; 53:897-905.
11. Rashid T, Ebringer A. Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry. Autoimmune Dis 2012; 2012:539282.
12. Rivas MN, Koh YT, Chen A etal. MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice. J Clin Invest 2012; 122:1933-1947.
13. Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JM, Brumfitt W, Sherlock S. Bacteriuria and primary biliary cirrhosis. Gut 1984; 25:133-137.
14. Varyani FK, West J, Card TR. An increased risk of urinary tract infection precedes development of primary biliary cirrhosis. BMC Gastroenterol 2011; 11:95.
15. Oertelt S, Rieger R, Selmi C etal. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007; 45:659-665.
16. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138:3525-3531.
17. Leung PS, Chuang DT, Wynn RM etal. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 1995; 22:505-513.
18. Moteki S, Leung PS, Dickson ER etal. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology 1996; 23:436-444.
19. Dubel L, Tanaka A, Leung PS etal. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 1999; 29:1013-1018.
20. Leung PS, Lam K, Kurth MJ, Coppel RL, Gershwin ME. Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? Trends Mol Med 2012; 18:577-582.
21. Liu H, Norman GL, Shums Z etal. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 2010; 35:436-442.
22. Moteki S, Leung PS, Coppel RL etal. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996; 24:97-9103.
23. Lleo A, Invernizzi P, Mackay IR, Prince H, Zhong RQ, Gershwin ME. Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol 2008; 14:3328-3337.
24. Shimoda S, Nakamura M, Ishibashi H etal. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 2003; 124:1915-1925.
25. Kita H, Naidenko OV, Kronenberg M etal. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002; 123:1031-1043.
26. Matsumura S, Kita H, He XS etal. Comprehensive mapping of HLA-A0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis. Hepatology 2002; 36:1125-1134.
27. Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995; 181:1835-1845.
28. Padgett KA, Selmi C, Kenny TP etal. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J Autoimmun 2005; 24:209-219.
29. Selmi C, Balkwill DL, Invernizzi P etal. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003; 38:1250-1257.
30. Mattner J, Savage PB, Leung P etal. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008; 3:304-315.
31. Mohammed JP, Fusakio ME, Rainbow DB etal. Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol 2011; 187:337-349.
32. Leung PS, Chu KH, Chow WK etal. Cloning, expression, and primary structure of Metapenaeus ensis tropomyosin, the major heat-stable shrimp allergen. J Allergy Clin Immunol 1994; 94:882-890.
33. Leung PS, Yang GX, Dhirapong A, Tsuneyama K, Ridgway WM, Gershwin ME. Animal models of primary biliary cirrhosis: materials and methods. Methods Mol Biol 2012; 900:291-316.
34. Brossay L, Tangri S, Bix M, Cardell S, Locksley R, Kronenberg M. Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets. J Immunol 1998; 160:3681-3688.
35. Naidenko OV, Maher JK, Ernst WA, Sakai T, Modlin RL, Kronenberg M. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med 1999; 190:1069-1080.
36. Yoshida K, Yang GX, Zhang W etal. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology 2009; 50:1494-1500.
37. Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 2004; 17:1141-1149.
38. Kinjo Y, Illarionov P, Vela JL etal. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 2011; 12:966-974.
39. Kinjo Y, Tupin E, Wu D etal. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006; 7:978-986.
40. Kinjo Y, Wu D, Kim G etal. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434:520-525.
41. Shigematsu H, Shimoda S, Nakamura M etal. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens. Hepatology 2000; 32:901-909.
42. He XS, Ansari AA, Ridgway WM, Coppel RL, Gershwin ME. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 2006; 239:1-13.
43. Shimoda S, Van de Water J, Ansari A etal. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998; 102:1831-1840.
44. Bogdanos DP, Baum H, Grasso A etal. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 2004; 40:31-39.
45. Bogdanos DP, Baum H, Okamoto M etal. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 2005; 42:458-465.
46. Bogdanos DP, Baum H, Sharma UC etal. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol 2002; 36:14-21.
47. Bogdanos DP, Koutsoumpas A, Baum H, Vergani D. Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis. Dig Liver Dis 2006; 38:781-782.
48. Shimoda S, Nakamura M, Shigematsu H etal. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000; 31:1212-1216.
49. Burroughs AK, Butler P, Sternberg MJ, Baum H. Molecular mimicry in liver disease. Nature 1992; 358:377-378.
50. Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J Hepatol 2004; 40:380-384.
51. Lee JW, Lee DH, Lee JI etal. Identification of Helicobacter pylori in gallstone, bile, and other hepatobiliary tissues of patients with cholecystitis. Gut Liver 2010; 4:60-67.
52. Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38:1072-1076.
53. Bogdanos DP, Baum H, Vergani D, Burroughs AK. The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers 2010; 29:301-311.
54. Bogdanos DP, Baum H, Gunsar F etal. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol 2004; 39:981-987.
55. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLOS Med 2006; 3:e297.
56. Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation? Hepatology 2001; 33:530-536.
57. Kinjo Y, Kronenberg M. Detection of microbes by natural killer T cells. Adv Exp Med Biol 2009; 633:17-26.
58. Nagarajan NA, Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 2007; 178:2706-2713.
59. Oertelt S, Lian ZX, Cheng CM etal. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006; 177:1655-1660.
60. Wakabayashi K, Lian ZX, Leung PS etal. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008; 48:531-540.
61. Haruta I, Kikuchi K, Hashimoto E etal. Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest 2010; 90:577-588.
62. Haruta I, Kikuchi K, Nakamura M etal. Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis. J Clin Immunol 2012; 32:1026-1037.
63. Hopf U, Moller B, Stemerowicz R etal. Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 1989; 2:1419-1422.
64. Butler P, Hamilton-Miller J, Baum H, Burroughs AK. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem Mol Biol Int 1995; 35:473-485.
65. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology 2001; 33:16-21.
66. Gershwin ME, Selmi C, Worman HJ etal. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005; 42:1194-1202.